Chinese companies lead ADC development pipeline: GlobalData
Express Pharma
MAY 6, 2024
A significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market. According to GlobalData, a significant level of increase is seen in Chinese companies within the Antibody-drug conjugates market. Half of the top 10 developers seek to capitalise on potential returns.
Let's personalize your content